Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Taro Pharmaceutical Industries Ltd.

TARO•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$42.98
$0.005(0.01%)
U.S. Market opens in 15h 48m

Taro Pharmaceutical Industries Ltd. (TARO) Stock Overview

Explore Taro Pharmaceutical Industries Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.6B
P/E Ratio29.99
EPS (TTM)$1.43
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$43.44

TARO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Taro Pharmaceutical Industries Ltd. (TARO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $43.44.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.99 and a market capitalization of 1.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.01%
3-Month Change
1.72%
6-Month Change
1.50%
Year-to-Date (YTD) Change
2.91%
1-Year Change
13.09%
3-Year Change
-39.10%
5-Year Change
-48.04%
All-Time (Max) Change
22820.00%

Contact Information

https://www.taro.com
972 4 847 5700
14 Hakitor Street, Haifa, NaN, 2624761

Company Facts

15,540 Employees
IPO DateSep 14, 1982
CountryIL

Frequently Asked Questions